Surmodics Shares Surge After Receiving Favorable Court Decision on Proposed Merger

Dow Jones

Nov 11

By Connor Hart

Shares of Surmodics jumped after a federal court denied a request from the Federal Trade Commission and state regulators to block the company's proposed acquisition by GTCR.

Shares climbed 49% to $40.77 in morning trading Tuesday. The stock is up 6% over the past year.

The medical-device maker said late Monday that the U.S. District Court for the Northern District of Illinois declined to issue a preliminary injunction that would have prevented the two sides from closing the transaction.

The ruling marks "a significant step toward being able to complete the merger, which we continue to believe will position the company to continue to deliver compelling benefits for physicians, patients and customers going forward," Chief Executive Gary Maharaj said.

Surmodics and GTCR are still bound by a temporary restraining order that bars them from completing the merger before 5 p.m. CT on Nov. 17, Surmodics said. The deal also remains subject to customary closing conditions, including the absence of any other legal prohibitions.

Write to Connor Hart at connor.hart@wsj.com

(END) Dow Jones Newswires

November 11, 2025 10:20 ET (15:20 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2582398856"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2582398856\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2582398856?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-11 23:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2582398856","market":"sg","top_or_hot":-1,"title":"Surmodics Shares Surge After Receiving Favorable Court Decision on Proposed Merger","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Connor Hart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Surmodics jumped after a federal court denied a request from the Federal Trade Commission and state regulators to block the company's proposed acquisition by GTCR. \n</p>\n<p>\n  Shares climbed 49% to $40.77 in morning trading Tuesday. The stock is up 6% over the past year. \n</p>\n<p>\n  The medical-device maker said late Monday that the U.S. District Court for the Northern District of Illinois declined to issue a preliminary injunction that would have prevented the two sides from closing the transaction. \n</p>\n<p>\n  The ruling marks \"a significant step toward being able to complete the merger, which we continue to believe will position the company to continue to deliver compelling benefits for physicians, patients and customers going forward,\" Chief Executive Gary Maharaj said. \n</p>\n<p>\n  Surmodics and GTCR are still bound by a temporary restraining order that bars them from completing the merger before 5 p.m. CT on Nov. 17, Surmodics said. The deal also remains subject to customary closing conditions, including the absence of any other legal prohibitions. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 11, 2025 10:20 ET (15:20 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Surmodics Shares Surge After Receiving Favorable Court Decision on Proposed Merger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSurmodics Shares Surge After Receiving Favorable Court Decision on Proposed Merger\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-11-11 23:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  By Connor Hart \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of Surmodics jumped after a federal court denied a request from the Federal Trade Commission and state regulators to block the company's proposed acquisition by GTCR. \n</p>\n<p>\n  Shares climbed 49% to $40.77 in morning trading Tuesday. The stock is up 6% over the past year. \n</p>\n<p>\n  The medical-device maker said late Monday that the U.S. District Court for the Northern District of Illinois declined to issue a preliminary injunction that would have prevented the two sides from closing the transaction. \n</p>\n<p>\n  The ruling marks \"a significant step toward being able to complete the merger, which we continue to believe will position the company to continue to deliver compelling benefits for physicians, patients and customers going forward,\" Chief Executive Gary Maharaj said. \n</p>\n<p>\n  Surmodics and GTCR are still bound by a temporary restraining order that bars them from completing the merger before 5 p.m. CT on Nov. 17, Surmodics said. The deal also remains subject to customary closing conditions, including the absence of any other legal prohibitions. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Connor Hart at connor.hart@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  November 11, 2025 10:20 ET (15:20 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SRDX","symbol_name":"SurModics","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2582398856","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2582398856","pubTimestamp":1762874400,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of Surmodics jumped after a federal court denied a request from the Federal Trade Commission and state regulators to block the company's proposed acquisition by GTCR.Shares climbed 49% to $40.77 in morning trading Tuesday. The stock is up 6% over the past year.The medical-device maker said late Monday that the U.S. District Court for the Northern District of Illinois declined to issue a preliminary injunction that would have prevented the two sides from closing the transaction.The ruling marks \"a significant step toward being able to complete the merger, which we continue to believe will position the company to continue to deliver compelling benefits for physicians, patients and customers going forward,\" Chief Executive Gary Maharaj said.Surmodics and GTCR are still bound by a temporary restraining order that bars them from completing the merger before 5 p.m. CT on Nov. 17, Surmodics said. The deal also remains subject to customary closing conditions, including the absence of an","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SRDX":"SurModics","BK4082":"医疗保健设备"},"translate_title":"Surmodics股价在收到法院对拟议合并的有利裁决后飙升","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SRDX":1.5},"content_text":"By Connor Hart \n\n\n \n\n\n  Shares of Surmodics jumped after a federal court denied a request from the Federal Trade Commission and state regulators to block the company's proposed acquisition by GTCR. \n\n\n  Shares climbed 49% to $40.77 in morning trading Tuesday. The stock is up 6% over the past year. \n\n\n  The medical-device maker said late Monday that the U.S. District Court for the Northern District of Illinois declined to issue a preliminary injunction that would have prevented the two sides from closing the transaction. \n\n\n  The ruling marks \"a significant step toward being able to complete the merger, which we continue to believe will position the company to continue to deliver compelling benefits for physicians, patients and customers going forward,\" Chief Executive Gary Maharaj said. \n\n\n  Surmodics and GTCR are still bound by a temporary restraining order that bars them from completing the merger before 5 p.m. CT on Nov. 17, Surmodics said. The deal also remains subject to customary closing conditions, including the absence of any other legal prohibitions. \n\n\n \n\n\n  Write to Connor Hart at connor.hart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 11, 2025 10:20 ET (15:20 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}